GEORGE FOUNTZILAS
机构: Professor Emeritus, Aristotle University of Thessaloniki
主页: fountzilas.gr
每年引用次数
引用次数
引用: 33,185
H-指数: 83
I10-指数 : 497
出版物: 1,104
Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
D. Pectasides , E. Pectasides , G. Papaxoinis , C. Andreadis
Gynecologic Oncology 115 ( 1) 97 -101
34
2009
Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)
P. A. Kosmidis , C. Kalofonos , K. Syrigos , D. Skarlos
Journal of Clinical Oncology 23 7000 -7000
12
2005
Evaluation of the prognostic value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy (DSAC)
D. Skarlos , H. Gogas , V. Kiriakou , A. Margariti
Journal of Clinical Oncology 23 627 -627
10
2005
Abstract P2-09-15: TOP2A and DARPP32 Are Associated with Response to Trastuzumab-Based Treatment of HER2-Positive Advanced Breast Cancer (ABC)
V Kotoula , M Bobos , KT Kalogeras , E Timotheadou
Cancer Research 70
2010
Abstract P2-09-18: High VEGFR1 and VEGFR3 Protein Expression Is Associated with Improved Response to the Combination of Paclitaxel (P) and Bevacizumab (Bev) Therapy in Patients with HER2-Negative Metastatic Breast Cancer (MBC)
C Papadimitriou , H Kourea , K Papazisis , C Christodoulou
Cancer Research 70
2010
Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx.
G. Pentheroudakis , I. Nicolaou , V. Kotoula , E. Fountzilas
Oral Oncology 48 ( 8) 709 -716
13
2012
Predictive markers for the treatment of colorectal cancer with cetuximab
E. Razis , E. Briasoulis , I. Kostopoulos , M. Bobos
Journal of Clinical Oncology 24 13500 -13500
2
2006
Piperacillin/tazobactam monotherapy versus combination ceftazidime plus amikacin for the treatment of febrile neutropenia in patients with cancer: A Hellenic Co-Operative Oncology Group Study
D. Pectasides , G. Fountzilas , G. Samonis , D. Panidis
Journal of Clinical Oncology 24 ( 18_suppl) 18590 -18590
2006
A randomised phase II study comparing irinotecan (IRI) plus leucovorin (LV) and 5-fluorouracil (5FU) versus IRI-LV-5FU followed be oxaliplatin (OXA) plus LV-5FU in patients with previously untreated metastatic colorectal cancer (CRC)
H. P. Kalofonos , P. Papakostas , G. Aravantinos , C. Papadimitriou
Journal of Clinical Oncology 24 ( 18_suppl) 3583 -3583
2006
A phase II study of sunitinib administered in a continuous daily regimen in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC)
P. H. De Mulder , J. Roigas , S. Gillessen , S. Srinivas
Journal of Clinical Oncology 24 4529 -4529
39
2006
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for frontline chemotherapy of advanced ovarian carcinoma (AOC): A Hellenic Cooperative Oncology Group Study
G. Aravantinos , G. Fountzilas , H. P. Kalofonos , D. V. Skarlos
Journal of Clinical Oncology 24 5074 -5074
2006
Prognostic value of VEGFC, HER2 and HER3 gene expression in recurrent squamous cell head and neck tumors
G. Fountzilas , N. Angouridakis , R. M. Wirtz , S. Claas
Journal of Clinical Oncology 24 5538 -5538
2
2006
Correlation of molecular HLA typing and outcome in high-risk melanoma patients receiving adjuvant interferon
H. Gogas , M. Spyropoulou-Vlachou , U. Dafni , D. Tsoutsos
Journal of Clinical Oncology 24 8029 -8029
1
2006
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A hellenic cooperative oncology group study
G. Aravantinos , D.V. Skarlos , P. Kosmidis , A. Athanassiades
European Journal of Cancer 33 ( 1) 160 -163
13
1997
Effectiveness of paclitaxel and carboplatin combination in heavily pretreated patients with head and neck cancers
G.P. Stathopoulos , S. Rigatos , P. Papakostas , G. Fountzilas
European Journal of Cancer 33 ( 11) 1780 -1783
21
1997
Paclitaxel by 3-H infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the hellenic cooperative oncology group
G. Fountzilas , A. Athanassiadis , A. Kalogera-Fountzila , G. Aravantinos
European Journal of Cancer 33 ( 11) 1893 -1895
30
1997
Fluorouracil (5-FU) and follinic acid (FA) with or without a2b-interferon (IFN) in advanced colorectal cancer (ACC). A prospective randomized trial
P. Kosmidis , N. Tsavaris , D. Skarlos , N. Pavlidis
European Journal of Cancer 29
7
1993
Intraperitoneal administration (I.P.) of interferon-a (IFN-a) in patients with ovarian CA, in clinical complete remission (cCR) following chemotherapy with high doses of carboplatin (C) and haemopoetic growth factors (H.G.F.)
P. Kosmidis , D. Bafaloukos , G. Fountzilas , P. Markantonakis
European Journal of Cancer 29
1993
Interferon-alpha (IFN-a) in combination with carboplatin (C) vinblastine (V) and bleomycin (B) in metastatic malignant melanoma (M.M.)
D. Bafaloukos , N. Pavlidis , D. Skarlos , G. Fountzilas
European Journal of Cancer 29
1993
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer☆
G. Fountzilas , D. Skarlos , T. Giannakakis , A. Athanasiades
European Journal of Cancer 30 ( 7) 965 -969
15
1994